The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Oestrogens for preventing recurrent urinary tract infection in postmenopausal women
Open accessAbstract
BACKGROUND: Recurrent urinary tract infection (RUTI) is defined as three episodes of urinary tract infection (UTI) in the previous 12 months or two episodes in the last six months. The main factors associated with RUTI in postmenopausal women are vesical prolapse, cystocoele, post-voidal residue and urinary incontinence, all associated with a decrease in oestrogen. The use of oestrogens to prevent RUTI has been proposed. OBJECTIVES: To estimate the efficacy and safety of oral or vaginal oestrogens for preventing RUTI in postmenopausal women. SEARCH STRATEGY: We searched the Cochrane Renal Group's specialised register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (from 1950), EMBASE (from 1980), reference lists of articles without language restriction. Date of last search: February 2007. SELECTION CRITERIA: Randomised controlled trials (RCTs) in which postmenopausal women (more than 12 months since last menstrual period) diagnosed with RUTI received any type of oestrogen (oral , vaginal) versus placebo or any other intervention were included. DATA COLLECTION AND ANALYSIS: Authors extracted data and assessed quality. Statistical analyses were performed using the random effects model and the results expressed as relative risk (RR) for dichotomous outcomes or mean difference (WMD) for continuous data with 95% confidence intervals (CI). MAIN RESULTS: Nine studies (3345 women) were included. Oral oestrogens did not reduce UTI compared to placebo (4 studies, 2798 women: RR 1.08, 95% CI 0.88 to 1.33). Vaginal oestrogens versus placebo reduced the number of women with UTIs in two small studies using different application methods. The RR for one was 0.25 (95% CI 0.13 to 0.50) and 0.64 (95% CI 0.47 to 0.86) in the second. Two studies compared oral antibiotics versus vaginal oestrogens (cream (1), pessaries (1)). There was very significant heterogeneity and the results could not be pooled. Vaginal cream reduced the proportion of UTIs compared to antibiotics in one study and in the second study antibiotics were superior to vaginal pessaries. Adverse events for vaginal oestrogens were breast tenderness, vaginal bleeding or spotting, nonphysiologic discharge, vaginal irritation, burning and itching. AUTHORS' CONCLUSIONS: Based on only two studies comparing vaginal oestrogens to placebo, vaginal oestrogens reduced the number of UTIs in postmenopausal women with RUTI, however this varied according to the type of oestrogen used and the treatment duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Foxman, B., Barlow, R., D'Arcy, H., Gillespie, B., & Sobel, J. D. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00072-7 · Cited by 1,447
Raz, R., & Stamm, W. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291102 · Cited by 928
Cranberries for preventing urinary tract infections
Jepson, R., Mihaljevic, L., & Craig, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001321.pub3 · Cited by 623
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 601
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women
Albert, X., Huertas, I., Pereiro, I., Sanfélix, J., Gosalbes, V., & Perrotta, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001209.pub2 · Cited by 419
Self-citationPrevalence of urinary incontinence and associated risk factors in postmenopausal women
Brown, J. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00263-x · Cited by 410
Estrogen receptors in the human female lower urinary tract
Iosif, C. S., Batra, S. C., Ek, A., & Åstedt, B. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90710-9 · Cited by 383
Local oestrogen for vaginal atrophy in postmenopausal women
Suckling, J. A., Kennedy, R., Lethaby, A., & Roberts, H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub2 · Cited by 359
Eriksen, B. C. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70597-1 · Cited by 336
Recurrent Urinary Tract Infections in Postmenopausal Women
Raz, R., Gennesin, Y., Wasser, J., Stoler, Z., Rosenfeld, S., Rottensterich, E., & Stamm, W. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313596 · Cited by 324
The role of estrogens in female lower urinary tract dysfunction
Robinson, D., & Cardozo, L. D. (2003) · Urology · doi:10.1016/s0090-4295(03)00676-9 · Cited by 290
Oestrogens for urinary incontinence in women
Moehrer, B., Hextall, A., & Jackson, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001405 · Cited by 176
Risk Factors for Urinary Tract Infections in Postmenopausal Women
Hu, K. K., Boyko, E. J., Scholes, D., Normand, E., Chen, C.-L., Grafton, J., & Fihn, S. D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.989 · Cited by 159
Henriksson, L., Stjernquist, M., Boquist, L., et al. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70378-2 · Cited by 145
Ayton, R. A., Darting, G. M., Murkies, A. L., Farrell, E. A., Weisberg, E., Selinus, I., & Fraser, I. S. (1996) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1996.tb09741.x · Cited by 139
Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors
Brown, J. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01630-1 · Cited by 127
Raz, R., Colodner, R., Rohana, Y., Battino, S., Rottensterich, E., Wasser, I., & Stamm, W. E. (2003) · Clinical Infectious Diseases · doi:10.1086/374341 · Cited by 107
Oestriol in the Prophylactic Treatment of Recurrent Urinary Tract Infections in Postmenopausal Women
Kirkengen, A. L., Andersen, P., Gjersøe, E., Johannessen, G. R., Johnsen, N., & Bodd, E. (1992) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813439209014051 · Cited by 87
Urinary tract infection among women aged 40 to 65
Foxman, B., Somsel, P. A., Tallman, P. A., Gillespie, B. W., Raz, R., Colodner, R., Kandula, D., & Sobel, J. D. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00352-8 · Cited by 83
Ouslander, J. G., Greendale, G. A., Uman, G. C., Lee, C. M., Paul, W., & Schnelle, J. F. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49160.x · Cited by 69
Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause
Molander, U., Milsom, I., Ekelund, P., Mellström, D., & Eriksson, O. (1990) · Maturitas · doi:10.1016/0378-5122(90)90089-o · Cited by 69
Raz, R. (2001) · The Journal of Infectious Diseases · doi:10.1086/318842 · Cited by 64
Urinary Tract Infections and Estrogen Use in Older Women
Orlander, J. D., Jick, S. S., Dean, A. D., & Jick, H. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01855.x · Cited by 58
Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis
Marx, P., Schade, G., Wilbourn, S., Blank, S., Moyer, D. L., & Nett, R. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00240-8 · Cited by 42
Cited by
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Terlizzi, M. E., Gribaudo, G., & Maffei, M. E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01566 · Cited by 692
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Portman, D. J., Gass, M. L. S., & Panel, O. B. O. T. V. A. T. C. C. (2014) · Climacteric · doi:10.3109/13697137.2014.946279 · Cited by 407
Takahashi, T. A., & Johnson, K. M. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.006 · Cited by 355
Metadata
- Authors
- Perrotta, C., Aznar, M., Mejia, R., Albert, X., & Ng, C. W.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2008-04-23
- Volume
- 2010
- Issue
- 1
- Pages
- CD005131-CD005131
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1744428405
- Cited by
- 350
- References
- 26
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.